Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Herpes Simplex Virus (HSV) Vaccines Market Growth 2022-2028

  • LP 4767492
  • 78 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Herpes Simplex Virus (HSV) Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Herpes Simplex Virus (HSV) Vaccines market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Herpes Simplex Virus (HSV) Vaccines market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Herpes Simplex Virus (HSV) Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Herpes Simplex Virus (HSV) Vaccines market, reaching US$ million by the year 2028. As for the Europe Herpes Simplex Virus (HSV) Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Herpes Simplex Virus (HSV) Vaccines players cover Sanofi, GlaxoSmithKline, Genocea Biosciences, and Vical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Herpes Simplex Virus (HSV) Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

GEN-003

VCL-HB01

HSV529

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

HSV-1 (Oral Herpes)

HSV-2 (Genital Herpes)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Sanofi

GlaxoSmithKline

Genocea Biosciences

Vical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Herpes Simplex Virus (HSV) Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Herpes Simplex Virus (HSV) Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Herpes Simplex Virus (HSV) Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Herpes Simplex Virus (HSV) Vaccines Segment by Type

2.2.1 GEN-003

2.2.2 VCL-HB01

2.2.3 HSV529

2.2.4 Others

2.3 Herpes Simplex Virus (HSV) Vaccines Sales by Type

2.3.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Type (2017-2022)

2.4 Herpes Simplex Virus (HSV) Vaccines Segment by Application

2.4.1 HSV-1 (Oral Herpes)

2.4.2 HSV-2 (Genital Herpes)

2.5 Herpes Simplex Virus (HSV) Vaccines Sales by Application

2.5.1 Global Herpes Simplex Virus (HSV) Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Application (2017-2022)

3 Global Herpes Simplex Virus (HSV) Vaccines by Company

3.1 Global Herpes Simplex Virus (HSV) Vaccines Breakdown Data by Company

3.1.1 Global Herpes Simplex Virus (HSV) Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Herpes Simplex Virus (HSV) Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2020-2022)

3.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Company

3.4 Key Manufacturers Herpes Simplex Virus (HSV) Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Herpes Simplex Virus (HSV) Vaccines Product Location Distribution

3.4.2 Players Herpes Simplex Virus (HSV) Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Herpes Simplex Virus (HSV) Vaccines by Geographic Region

4.1 World Historic Herpes Simplex Virus (HSV) Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Herpes Simplex Virus (HSV) Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Herpes Simplex Virus (HSV) Vaccines Annual Revenue by Geographic Region

4.2 World Historic Herpes Simplex Virus (HSV) Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Herpes Simplex Virus (HSV) Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Herpes Simplex Virus (HSV) Vaccines Annual Revenue by Country/Region

4.3 Americas Herpes Simplex Virus (HSV) Vaccines Sales Growth

4.4 APAC Herpes Simplex Virus (HSV) Vaccines Sales Growth

4.5 Europe Herpes Simplex Virus (HSV) Vaccines Sales Growth

4.6 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Growth

5 Americas

5.1 Americas Herpes Simplex Virus (HSV) Vaccines Sales by Country

5.1.1 Americas Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022)

5.1.2 Americas Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022)

5.2 Americas Herpes Simplex Virus (HSV) Vaccines Sales by Type

5.3 Americas Herpes Simplex Virus (HSV) Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Herpes Simplex Virus (HSV) Vaccines Sales by Region

6.1.1 APAC Herpes Simplex Virus (HSV) Vaccines Sales by Region (2017-2022)

6.1.2 APAC Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2022)

6.2 APAC Herpes Simplex Virus (HSV) Vaccines Sales by Type

6.3 APAC Herpes Simplex Virus (HSV) Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Herpes Simplex Virus (HSV) Vaccines by Country

7.1.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022)

7.1.2 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022)

7.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type

7.3 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines by Country

8.1.1 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type

8.3 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Herpes Simplex Virus (HSV) Vaccines

10.3 Manufacturing Process Analysis of Herpes Simplex Virus (HSV) Vaccines

10.4 Industry Chain Structure of Herpes Simplex Virus (HSV) Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Herpes Simplex Virus (HSV) Vaccines Distributors

11.3 Herpes Simplex Virus (HSV) Vaccines Customer

12 World Forecast Review for Herpes Simplex Virus (HSV) Vaccines by Geographic Region

12.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Region

12.1.1 Global Herpes Simplex Virus (HSV) Vaccines Forecast by Region (2023-2028)

12.1.2 Global Herpes Simplex Virus (HSV) Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Herpes Simplex Virus (HSV) Vaccines Forecast by Type

12.7 Global Herpes Simplex Virus (HSV) Vaccines Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Herpes Simplex Virus (HSV) Vaccines Product Offered

13.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 GlaxoSmithKline

13.2.1 GlaxoSmithKline Company Information

13.2.2 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Offered

13.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline Main Business Overview

13.2.5 GlaxoSmithKline Latest Developments

13.3 Genocea Biosciences

13.3.1 Genocea Biosciences Company Information

13.3.2 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Offered

13.3.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Genocea Biosciences Main Business Overview

13.3.5 Genocea Biosciences Latest Developments

13.4 Vical

13.4.1 Vical Company Information

13.4.2 Vical Herpes Simplex Virus (HSV) Vaccines Product Offered

13.4.3 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Vical Main Business Overview

13.4.5 Vical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Herpes Simplex Virus (HSV) Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Herpes Simplex Virus (HSV) Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of GEN-003

Table 4. Major Players of VCL-HB01

Table 5. Major Players of HSV529

Table 6. Major Players of Others

Table 7. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)

Table 8. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2022)

Table 9. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2022) & ($ million)

Table 10. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2017-2022)

Table 11. Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)

Table 13. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2022)

Table 14. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2022)

Table 15. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2017-2022)

Table 16. Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Herpes Simplex Virus (HSV) Vaccines Sales by Company (2020-2022) & (K Units)

Table 18. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2020-2022)

Table 19. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company (2020-2022)

Table 21. Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Herpes Simplex Virus (HSV) Vaccines Producing Area Distribution and Sales Area

Table 23. Players Herpes Simplex Virus (HSV) Vaccines Products Offered

Table 24. Herpes Simplex Virus (HSV) Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Herpes Simplex Virus (HSV) Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share Geographic Region (2017-2022)

Table 29. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Herpes Simplex Virus (HSV) Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country/Region (2017-2022)

Table 33. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022) & (K Units)

Table 36. Americas Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2017-2022)

Table 37. Americas Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2017-2022)

Table 39. Americas Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)

Table 40. Americas Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2022)

Table 41. Americas Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)

Table 42. Americas Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2022)

Table 43. APAC Herpes Simplex Virus (HSV) Vaccines Sales by Region (2017-2022) & (K Units)

Table 44. APAC Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2017-2022)

Table 45. APAC Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2017-2022)

Table 47. APAC Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)

Table 48. APAC Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2022)

Table 49. APAC Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)

Table 50. APAC Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2022)

Table 51. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022) & (K Units)

Table 52. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2017-2022)

Table 53. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2017-2022)

Table 55. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)

Table 56. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2022)

Table 57. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)

Table 58. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Herpes Simplex Virus (HSV) Vaccines

Table 68. Key Market Challenges & Risks of Herpes Simplex Virus (HSV) Vaccines

Table 69. Key Industry Trends of Herpes Simplex Virus (HSV) Vaccines

Table 70. Herpes Simplex Virus (HSV) Vaccines Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Herpes Simplex Virus (HSV) Vaccines Distributors List

Table 73. Herpes Simplex Virus (HSV) Vaccines Customer List

Table 74. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Forecast by Region

Table 76. Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 94. Sanofi Basic Information, Herpes Simplex Virus (HSV) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 95. Sanofi Herpes Simplex Virus (HSV) Vaccines Product Offered

Table 96. Sanofi Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Sanofi Main Business

Table 98. Sanofi Latest Developments

Table 99. GlaxoSmithKline Basic Information, Herpes Simplex Virus (HSV) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 100. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Offered

Table 101. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. GlaxoSmithKline Main Business

Table 103. GlaxoSmithKline Latest Developments

Table 104. Genocea Biosciences Basic Information, Herpes Simplex Virus (HSV) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 105. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Offered

Table 106. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Genocea Biosciences Main Business

Table 108. Genocea Biosciences Latest Developments

Table 109. Vical Basic Information, Herpes Simplex Virus (HSV) Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 110. Vical Herpes Simplex Virus (HSV) Vaccines Product Offered

Table 111. Vical Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Vical Main Business

Table 113. Vical Latest Developments

List of Figures

Figure 1. Picture of Herpes Simplex Virus (HSV) Vaccines

Figure 2. Herpes Simplex Virus (HSV) Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Herpes Simplex Virus (HSV) Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of GEN-003

Figure 10. Product Picture of VCL-HB01

Figure 11. Product Picture of HSV529

Figure 12. Product Picture of Others

Figure 13. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2021

Figure 14. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2017-2022)

Figure 15. Herpes Simplex Virus (HSV) Vaccines Consumed in HSV-1 (Oral Herpes)

Figure 16. Global Herpes Simplex Virus (HSV) Vaccines Market: HSV-1 (Oral Herpes) (2017-2022) & (K Units)

Figure 17. Herpes Simplex Virus (HSV) Vaccines Consumed in HSV-2 (Genital Herpes)

Figure 18. Global Herpes Simplex Virus (HSV) Vaccines Market: HSV-2 (Genital Herpes) (2017-2022) & (K Units)

Figure 19. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2022)

Figure 20. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application in 2021

Figure 21. Herpes Simplex Virus (HSV) Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company in 2021

Figure 23. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Geographic Region in 2021

Figure 25. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2017-2022)

Figure 26. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country/Region in 2021

Figure 27. Americas Herpes Simplex Virus (HSV) Vaccines Sales 2017-2022 (K Units)

Figure 28. Americas Herpes Simplex Virus (HSV) Vaccines Revenue 2017-2022 ($ Millions)

Figure 29. APAC Herpes Simplex Virus (HSV) Vaccines Sales 2017-2022 (K Units)

Figure 30. APAC Herpes Simplex Virus (HSV) Vaccines Revenue 2017-2022 ($ Millions)

Figure 31. Europe Herpes Simplex Virus (HSV) Vaccines Sales 2017-2022 (K Units)

Figure 32. Europe Herpes Simplex Virus (HSV) Vaccines Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue 2017-2022 ($ Millions)

Figure 35. Americas Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2021

Figure 36. Americas Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country in 2021

Figure 37. United States Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region in 2021

Figure 42. APAC Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Regions in 2021

Figure 43. China Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2021

Figure 50. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country in 2021

Figure 51. Germany Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country in 2021

Figure 58. Egypt Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Herpes Simplex Virus (HSV) Vaccines in 2021

Figure 64. Manufacturing Process Analysis of Herpes Simplex Virus (HSV) Vaccines

Figure 65. Industry Chain Structure of Herpes Simplex Virus (HSV) Vaccines

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390